AGENDA AT A GLANCE

Day One - Wednesday, September 28

Updates on Your Current Framework for Biomarker & CDx Development

Biomarker Discovery
& Translational Development

Clinical Biomarker Development

CDx Development

Investigating Preclinical Cancer Biology

Managing Increasing Complexity Within the Next Promising Wave of Biomarker Development 

Exploring The Scope of Today’s Drug-Dx Co-Development 

Biomarker Discovery
& Translational Development

Clinical Biomarker Development

Exploring The Scope of Today’s Drug-Dx Co-Development 

Fast-Tracking Promising Biomarker Development By Leveraging Collaborative Industry Resources 

Defining Patient Populations 

Exploring The Scope of Today’s Drug-Dx Co-Development 

Alignment in Biomarker Development in an Increasingly Complex Biological Landscape

Day Two - Thursday, September 29

Establishing a Footprint in Competitive Global Markets

Biomarker Discovery
& Translational Development

Clinical Biomarker Development

CDx Commercialization

Tools & Techniques Driving Efficiencies in Biomarker Discovery 

Gaining a Strategic Advantage Through the Implementation of Latest Patient Stratification Approaches 

Creating & Maintaining Strong Market Access & Reimbursement Strategies

Biomarker Discovery
& Translational Development

Clinical Biomarker Development

CDx Commercialization

Next Generation Biomarker Discovery 

Earlier Intervention for Better Patient Outcomes 

Ensuring Access in Routine Practice 

Collectively Progressing Precision Medicine